Deere, Amgen, Copart And More: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners named Deere & Company (NYSE:DE) as his final trade.

On Wednesday, Citigroup analyst Kyle Menges maintained Deere with a Neutral and raised the price target from $395 to $420.

Jason Snipe of Odyssey Capital Advisors said Amgen Inc. (NASDAQ:AMGN) has got a really strong pipeline.

On Monday, Barclays analyst Carter Gould maintained Amgen with an Equal-Weight rating and raised the price target from $300 to $315.

Don't forget to check out our premarket coverage here

Shannon Saccocia of NB Private Wealth named iShares U.S. Healthcare ETF (NYSE:IYH).

Joseph M. Terranova of Virtus Investment Partners picked Copart, Inc. (NASDAQ:CPRT), an industrial name.

On Sept. 4, Copart reported quarterly earnings of 33 cents per share, which missed the analyst consensus estimate by 8.33%. Quarterly revenue came in at $1.068 billion, which missed the analyst consensus estimate of $1.081 billion. Gross profit and net income were $454 million and $323 million, respectively.

Price Action:

• Deere gained 1.3% to close at $405.48 during Wednesday's session.
• Amgen shares gained 1.5% to close at $322.41 on Wednesday.
• iShares U.S. Healthcare ETF gained 1% during Wednesday's session.
• Copart shares gained 2.6% to settle at $55.84 on Wednesday.

Check This Out:

• S&P Settles At Record High As Apple, Amazon Shares Surge: Investor Optimism Improves Ahead Of Inflation Data

Image: Shutterstock